Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry
Open accessThe DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the frequency of continuous glucose monitoring (CGM) device use, factors associated with its use, and the relationship of CGM with diabetes outcomes (HbA1c, severe hypoglycemia [SH], and diabetic ketoacidosis [DKA]). RESEARCH DESIGN AND METHODS: Survey questions related to CGM device use 1 year after enrollment in the T1D Exchange clinic registry were completed by 17,317 participants. Participants were defined as CGM users if they indicated using real-time CGM during the prior 30 days. RESULTS: Nine percent of participants used CGM (6% of children <13 years old, 4% of adolescents 13 to <18 years, 6% of young adults 18 to <26 years, and 21% of adults ≥26 years). CGM use was more likely with higher education, higher household income, private health insurance, longer duration of diabetes, and use of insulin pump (P < 0.01 all factors). CGM use was associated with lower HbA1c in children (8.3% vs. 8.6%, P < 0.001) and adults (7.7% vs. 7.9%, P < 0.001). In adults, more frequent use of CGM (≥6 days/week) was associated with lower mean HbA1c. Only 27% of users downloaded data from their device at least once per month, and ≤15% of users reported downloading their device at least weekly. Among participants who used CGM at baseline, 41% had discontinued within 1 year. CONCLUSIONS: CGM use is uncommon but associated with lower HbA1c in some age-groups, especially when used more frequently. Factors associated with discontinuation and infrequent use of retrospective analysis of CGM data should be considered in developing next-generation devices and education on CGM use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such phenomena question the accuracy and credibility of CGM and make patients less reactive to alarms and less willing to retain them activated or even continue to use CGM [ 43 , 55 ].”
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Klonoff, D. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1231 · Cited by 724
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541 · cited 1×
“occasional) use of CGM is associated with better glycemic control, as measured by HbA1c (5,8), leading to a practice guideline recommending CGM for adults who are able to use it at least 6 days a week (9).”
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
Battelino, T., Phillip, M., Bratina, N., Nimri, R., Oskarsson, P., & Bolinder, J. (2011) · Diabetes Care · doi:10.2337/dc10-1989 · Cited by 490
The T1D exchange clinic registry
Beck, R. W., Tamborlane, W. V., Bergenstal, R. M., Miller, K. M., DuBose, S. N., Hall, C. A., & for the T1D Exchange Clinic Network (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1561 · Cited by 456
Self-citationThe effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Cited by
Items 201–300 of 338
Wearable Woes: Allergens in Diabetic Devices
Hartsough, E. M., & Hylwa, S. A. (2020) · Dermatitis · doi:10.1097/der.0000000000000673 · Cited by 15
Hirsch, I. B., Nardacci, E., & Verderese, C. A. (2019) · Diabetes Spectrum · doi:10.2337/ds18-0059 · Cited by 14
Self-citationSperling, M. A., Wolfsdorf, J. I., Menon, R. K., Tamborlane, W. V., Maahs, D. M., Battelino, T., & Phillip, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00021-x · Cited by 13
Self-citationAddressing disparities in technology use among patients with type 1 diabetes: a review
Kanbour, S., & Everett, E. M. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000840 · Cited by 13
Proceedings of the 14th Australasian database conference - Volume 17
Schewe, K., & Zhou, X. (2003) · Cited by 13
Technology to Reduce Hypoglycemia
Yeoh, E. C. K., & Choudhary, P. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815574547 · Cited by 12
“CGM has been available for over a decade and in the US, less than 10% of people with diabetes use it.(60) Adoption of these technologies may be limited due to regulated funding from existing health care systems, medical reimbursements, and insurance, but also possibly due to lack of awareness and training of health ca…”
BackgroundTime in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
Yoo, J. H., & Kim, J. H. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0256 · Cited by 12
Future technology-enabled care for diabetes and hyperglycemia in the hospital setting
Montero, A. R., Dubin, J. S., Sack, P., & Magee, M. F. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i9.473 · Cited by 12
An Expert Opinion on Advanced Insulin Pump Use in Youth with Type 1 Diabetes
Bode, B. W., KAUFMAN, F. R., & Vint, N. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0354 · Cited by 12
“…data such as how much basal, bolus (amount and number of boluses), and correction-dose insulin are used daily; how often patients are adding bolus insulin; how the bolus calculator is being used; how often the infusion sets are being changed; and CGM and blood glucose data 17 (Supplementary Figs.”
Self-citationDiabetes Technological Revolution: Winners and Losers?
Barnard-Kelly, K. D., & Breton, M. D. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818788872 · Cited by 12
Abraham, M. B., Heels, K., Nicholas, J. A., Cole, C., Gebert, R., Klimek, J., Jopling, T., Ambler, G. R., Cameron, F. J., Davis, E. A., et al. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817752188 · Cited by 11
Nally, L. M., Wagner, J. A., Sherr, J. L., TICHY, E. M., Weyman, K., Ginley, M. K., Zajac, K., Desousa, M., Shabanova, V., Petry, N. M., et al. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.11.017 · Cited by 11
Continuous Subcutaneous Insulin Infusions: Closing the Loop
Díaz-Balzac, C. A., Pillinger, D., & Wittlin, S. D. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac746 · Cited by 11
Berg, A. K., Grauslund, A. C., Sørensen, F., Thorsen, S. U., Thyssen, J. P., Zachariae, C. O. C., & Svensson, J. (2023) · Diabetes Care · doi:10.2337/dc23-0462 · Cited by 11
Understanding Reflection Needs for Personal Health Data in Diabetes
Prioleau, T., Sabharwal, A., & Vasudevan, M. M. (2020) · International Conference on Pervasive Computing Technologies for Healthcare · doi:10.1145/3421937.3421972 · Cited by 11
Teasdale, S., Griffin, A., Barrett, H. L., Coutts, C., Vitanza, M., & Headey, A. (2022) · Diabetes Spectrum · doi:10.2337/ds21-0066 · Cited by 11
Dicks, J. H., McCann, L. J., Tolley, A., Barrell, A. M., Johnson, L., Kuhn, I. L., & Ford, J. A. (2025) · Pediatric Diabetes · doi:10.1155/pedi/8875203 · Cited by 10
“Three US studies assessed how CGM use varied according to parental education; lower parental education was signi fi cantly associated with lower CGM use on unadjusted and multivariable analysis [19, 23].”
InfluentialThe Contemporary Role of Masked Continuous Glucose Monitoring in a Real-Time World
Blumer, I. R. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815619182 · Cited by 10
Has subsidized continuous glucose monitoring improved outcomes in pediatric diabetes?
Swaney, E. E. K., McCombe, J., Coggan, B., Donath, S. M., O’Connell, M. A., & Cameron, F. J. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13106 · Cited by 10
Continuous Glucose Monitoring in 2014
Bode, B. W., & Battelino, T. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.1502 · Cited by 10
“001), but also with a more affluent social status (1).”
InfluentialSelf-citationGingras, V., Desjardins, K., Smaoui, M. R., Savard, V., Messier, V., Haidar, A., Legault, L., & RABASA-LHORET, R. P. R. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1085-8 · Cited by 10
Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Ga, F., & Heinemann, L. (2018) · Yearbook of pediatric endocrinology · doi:10.1530/ey.15.10.9 · Cited by 10
Marks, B. E., Waldman, G., Reardon, K., Terrio, S., Kumar, A., Stafford, D. E. J., Garvey, K. C., & Wolfsdorf, J. I. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13010 · Cited by 10
Hanaire, H. P., Atlan, C., Benhamou, P., Bismuth, É., Bonnemaison, É., Borot, S., Catargi, B., Charpentier, G., Farret, A., Filhol, N., et al. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30030-0 · Cited by 10
Baumann, S., Stone, R., Genschel, U., & Mgaedeh, F. Z. (2023) · International Journal of Human-Computer Interaction · doi:10.1080/10447318.2023.2201552 · Cited by 9
“Wonget al. (2014) reported similar results where nearly half of all users (727 of 1,662) stopped wearing a glucose monitoring device after 1 year due to general discomfort (42%), with some developing a skin reaction caused by the device (18%).”
Deeb, A., Ziaullah, M., Aklé, M., & Strauss, K. W. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818801361 · Cited by 9
Sinisterra, M., Wang, C. H., Marks, B. E., Barber, J. R., Tully, C., Monaghan, M. C., Hilliard, M. E., & Streisand, R. M. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0183 · Cited by 9
Cowart, K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819890865 · Cited by 9
Swarm hybrid optimization for a piecewise model fitting applied to a glucose model
Acedo, L., Botella, M., Cortés, J. ‐., Hidalgo, J. I., Maqueda, E., & Villanueva, R. J. (2018) · Journal of Systems and Information Technology · doi:10.1108/jsit-10-2017-0103 · Cited by 8
Crocket, H. R., Elbashy, M. M., Kavanagh, T., Styles, S. E., Galland, B. C., Haszard, J. J., Wiltshire, E. J., Jefferies, C., de Bock, M. I., Tomlinson, P. A., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14731 · Cited by 8
Diabetes Technology and the Human Factor
Liberman, A., & Barnard, K. D. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.2511 · Cited by 8
“According to the data taken from the T1DX CGM, uptake rates among type 1 diabetes patients remains relatively low despite the reported benefits of CGM on glycemic control as well as health-related quality of life and treatment satisfaction (4).”
Giza, S., Kotanidou, E. P., Tsinopoulou, V. R., Poukoulidou, T., Ntouma, S., & Galli-Tsinopoulou, A. (2025) · Children · doi:10.3390/children12121668 · Cited by 7
“Studies recorded the impact of alarm fatigue among patients [18,29,31,33,34,36,43– 45,47 ,49 ,53 , 55 ], their parents [22 ,27 ,32,35,38,42,46, The main reasons responsible for alarm fatigue concerned either everyday life [22,25,29,31,33,34,37,39,41,43,45,46,49,51,52] or sleep [18,25,27,29,31–38,…”
Sheng, T., Offringa, R., Kerr, D. E., Clements, M. A., Fischer, J., Parks, L. J., & Greenfield, M. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819873641 · Cited by 7
DeSalvo, D. J., Km, M., Hermann, J., Maahs, D. M., Hofer, S., Ma, C., Lilienthal, E., Sherr, J. L., Tauschmann, M., Holl, R. W., et al. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.10.9 · Cited by 7
Self-citationAbraham, M. B., Smith, G. J., Nicholas, J. A., Fairchild, J. M., King, B. R., Ambler, G. R., Cameron, F. J., Davis, E. A., & Jones, T. W. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107989 · Cited by 7
A Position Statement of the Utilization and Support Status of Continuous Glucose Monitoring in Korea
Kim, W. J., Kim, J. H., Yoo, H. J., Son, J. W., Khang, A. R., Kwon, S. K., Kim, J. H., Kim, T. H., Ryu, O. H., Park, K. H., et al. (2021) · Journal of Korean Diabetes · doi:10.4093/jkd.2021.22.4.225 · Cited by 7
Ray, M. K., McMichael, A., Rivera-Santana, M. V., Noel, J., & Hershey, T. G. (2021) · JMIR Diabetes · doi:10.2196/27027 · Cited by 6
Wetter, S. E., Himelhoch, A. C., & Driscoll, K. A. (2024) · Current Diabetes Reports · doi:10.1007/s11892-023-01527-x · Cited by 6
“Moreover, provider bias regarding insurance affects whether diabetes devices are prescribed [21 •• ]; youth and adults who are prescribed CGMs often have private insurance, and higher household income and education [22].”
Type 1 Diabetes in Children and Adolescents
Sikes, K. A., Name, M. A. V., & Tamborlane, W. V. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_31 · Cited by 6
Tiano, S. M., Moczygemba, L. R., Hinds, A., Jokerst, J. R., Litten, K. P., Roscoe, C. A., & Sharma, R. (2025) · JAPhA Practice Innovations · doi:10.1016/j.japhpi.2025.100045 · Cited by 5
McKechnie, V., Avari, P., Eng, P. C., Unsworth, R., Reddy, M., Amiel, S. A., Salem, V., & Misra, S. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320702 · Cited by 5
“These results were confirmed in other studies [14].”
Pilot Study of Early Adoption of Automated Insulin Delivery in Underresourced Youth
Yen, K., Belapurkar, S., Puckett, C., Chen, N. S., YGLECIAS, L., Bal, K., Hickey, J., CARELLI, L. L., LOUCEL, C. M., Lodish, M. B., et al. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/6886806 · Cited by 5
“Despite these advances, disparities in the uptake and usage of diabetes devices have been well described [3 – 7].”
Self-citationChushig-Muzo, D., Calero-Díaz, H., Fabelo, H. A., Årsand, E., van Dijk, P. R., & Soguero-Ruíz, C. (2024) · Applied Sciences · doi:10.3390/app14219870 · Cited by 5
Monitoreo Continuo de Glucosa. ¿Qué evidencia tenemos en pediatría?
Ayala, D. V. S., Forero, C., Mauricio Coll, B., Durán, P. A., & Céspedes, C. (2021) · Andes pediatrica · doi:10.32641/andespediatr.v92i4.2973 · Cited by 5
Grundman, J., PERKINS, A. G., Monaghan, M. C., Meighan, S., Streisand, R. M., & Marks, B. E. (2023) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2023.100319 · Cited by 5
Is Continuous Glucose Monitoring Underappreciated in the UK?
Parkin, C. G., Holloway, M., Truesdell, J., & Walker, T. C. (2017) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2017.13.02.76 · Cited by 5
Eleftheriadou, I., Didangelos, T., Pappas, A. C., Anastasiou, E., Vasilopoulos, C., Zoupas, C., Manes, C., Tsatsoulis, A. A., Benroubi, M., Pangalos, E., et al. (2019) · HORMONES · doi:10.1007/s42000-019-00153-1 · Cited by 5
Fremont, E. R., Slick, N. R., Willi, S. M., & Miller, V. A. (2021) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106211040424 · Cited by 5
Picard, S., Hanaire, H. P., Reznik, Y., Benhamou, P., Fendri, S., Dufaitre, L., Leutenegger, É., & Guerci, B. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0002 · Cited by 5
“31 Asthe roleofCGM data downloading and analysisonsubsequentglucose control inT1D patientsonMDI has never been assessed, we speculate that RT-CGM wear and/ or retrospective analysis have been important in glucose con-trol improvement as a component of global diabetes management and reinforced the…”
Socioeconomic factors: access to and use of diabetes technologies
Barry, S., Wagner, D. V., Stoeckel, M., & Harris, M. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817485-2.00011-0 · Cited by 5
Multi-modal wearable ambient display: an investigation of continuous glucose monitoring
Reich, J., & Dunne, L. E. (2016) · ACM International Symposium on Wearable Computers (ISWC) · doi:10.1145/2971763.2971801 · Cited by 5
“The analyzed studies reported issues related to the participants body or privacy, the participants ability to effectively manage the demands of the device, and participants lack of support system [16, 17, 18, 20, 23, 24, 26].”
BackgroundInfluentialJeter, K. M., Fisher, R. S., Traino, K. A., Dattilo, T., Allen, R. A., Anderson, M. P., Cutler, J., Sparling, D. P., & Beck, J. K. (2025) · Psychology Health & Medicine · doi:10.1080/13548506.2025.2575402 · Cited by 4
Expert Opinion Statement on Continuous Glucose Monitoring in Type 2 Diabetes in the Arab Gulf Region
Alshaikh, A., BAKHSH, A. M. K., Alsagheir, A., El-Laboudi, A. H., Al-Mohanadi, D. H., Alawadi, F., Elbadawi, H., Alzubaidi, L. M. Y., Al‐Sofiani, M. E., Farooqi, M. H., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251393740 · Cited by 4
La mesure continue du glucose chez l’enfant et l’adolescent
Tubiana‐Rufi, N., & Sierra, P. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30190-0 · Cited by 4
Kondo, T., Senokuchi, T., Morinaga, J., Miyashita, A., Yano, M., Takeda, H., Nishida, K., & Kubota, N. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14337 · Cited by 4
“However, few studies have assessed the reliability of CGM in this group with inconsistent outcomes 21 – 24 .”
Insulintherapie bei Diabetes mellitus
Lechleitner, M., Roden, M., Weitgasser, R., Ludvik, B. H., Fasching, P., Hoppichler, F., Kautzky‐Willer, A., Schernthaner, G., Prager, R., & Wascher, T. C. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0925-1 · Cited by 4
Adolescent ambivalence about diabetes technology—The Janus faces of automated care
Cameron, F. J., Arnold, M., & Gregory, J. W. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13423 · Cited by 4
Continuous Glucose Monitoring in Children and Adolescents with Congenital Adrenal Hyperplasia
Dubinski, I., Pozza, S. B., Debor, B., Nowotny, H. F., Reisch, N., Tschaidse, L., & Schmidt, H. (2023) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2023.2023-3-5 · Cited by 4
“(5) CGM is an established method for measuring glucose in the interstitial fluid in children and adults with type 1 diabetes (6-8).”
MethodVolkening, L. K., Gaffney, K. C., Katz, M. L., & Laffel, L. M. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816656208 · Cited by 4
Zafra‐Tanaka, J. H., Brañez‐Condorena, A., Soriano‐Moreno, D. R., & Taype-Rondán, Á. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820952065 · Cited by 4
Tiruneh, K. G., Sibhat, M. M., Getnet, A., Akele, M. A., Meno, A., & Zewde, A. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241303416 · Cited by 3
Ferrández, S. M. B., Gutiérrez, T. M., Ballarín, G. L., Lozano, M. F., & Francés, G. M. L. (2020) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.11.007 · Cited by 3
Ampudia‐Blasco, F. J., Ugarte, E., Chico, A. I., García-Alemán, J., & Galan-Barroso, M. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221087270 · Cited by 3
Comparison of LVQ and BP Neural Network in the Diagnosis of Diabetes and Retinopathy
Si, J., Zhang, Y., Hu, S., Sun, L., Li, S., Yang, H., Li, X., & Wang, Y. (2018) · Communications in computer and information science · doi:10.1007/978-981-13-2206-8_37 · Cited by 3
Miller, V. A., Xiao, R., & Willi, S. M. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0668 · Cited by 3
Gaulke, A., Giordano, J., & Grossman, D. S. (2023) · Medical Care · doi:10.1097/mlr.0000000000001917 · Cited by 3
Rathor, S., Singh, S., Sharma, N., Zahoor, I., & Bhyan, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13587-3.00012-6 · Cited by 3
Introducing the Pi-CON Methodology to Overcome Usability Deficits during Remote Patient Monitoring
Baumann, S., Stone, R., & Kim, J. Y. M. (2024) · Sensors · doi:10.3390/s24072260 · Cited by 3
Effect of CGM in the HbA1c and Coefficient of Variation of glucose in a pediatric sample
Lou, G., Larramona, G., Gutiérrez, T. M., & Ferrández, S. M. B. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.10.005 · Cited by 3
Type 1 Diabetes in Children and Adolescents
Hu, P., Name, M. A. V., Stephenson, K., Sikes, K. A., & Tamborlane, W. V. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_30 · Cited by 3
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2782 · Cited by 3
Self-citationInsulin Pumps and Artificial Pancreas
Taleb, N., Gingras, V., & RABASA-LHORET, R. P. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65407-7 · Cited by 3
Brohi, A. H., Hakim, A., Khan, M. J., Malik, E., Mugheri, D., Shaikh, F., Abbas, W., Baloch, N., Ashraf, Z., Mangi, A. A., et al. (2020) · doi:10.21203/rs.3.rs-35708/v1 · Cited by 3
Zooming In, Then Out: Why We Must Apply Human-Centered Design to Transform Diabetes Technology
Chao, E. C. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231213665 · Cited by 3
Li, M. M., Feldman, N., Tanzer, J. R., Tremblay, E. S., & Millington, K. (2025) · Diabetes Spectrum · doi:10.2337/ds24-0080 · Cited by 2
KIM, S., Kim, S. J., Cho, K. W., Song, K., Choi, Y., Chae, H. W., & Suh, J. (2026) · Pediatric Diabetes · doi:10.1155/pedi/9111583 · Cited by 2
“Many studies [35] have revealed that the use of CGM has shown better glycemic control, especially lower HbA1c levels, in children ( p 0 : 01).”
Kangas, T., & Ayala, R. A. (2023) · Salud Ciencia y Tecnología · doi:10.56294/saludcyt2023430 · Cited by 2
Mahmoudi, Z., Johansen, M. D., Nørgaard, H. H., Andersen, S., Pedersen‐Bjergaard, U., Tarnow, L., Christiansen, J. S., & Hejlesen, O. K. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815587935 · Cited by 2
Insulin, the patient, and the health professional
Heller, S. R., Durrant, A., & Tandon, N. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02450-8 · Cited by 2
Düzalan, Ö. B., & İnkaya, B. V. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.01.001 · Cited by 2
Landau, Z., Abiri, S., Gruber, N., Levy‐Shraga, Y., Brener, A., Lebenthal, Y., Barash, G., Pinhas‐Hamiel, O., & Rachmiel, M. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1227-7 · Cited by 2
Aljohani, R. A., Altaib, H. N., & Kofi, M. A. (2025) · Cureus · doi:10.7759/cureus.79705 · Cited by 1
“Recent studies have also explored the cost-effectiveness of CGM. Long-term benefits in terms of reduced healthcare costs and improved outcomes have been reported [13,14].”
Young Adult Diabetes Technology Use in Pediatric as Compared to Adult Practices
DeLacey, S. E., Rompicherla, S., Grundman, J., Fogel, N. R., Corathers, S. D., Agarwal, S., Izquierdo, R. E., Golden, L., Weissberg-Benchell, J. A., & Ebekozien, O. A. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.09.001 · Cited by 1
Alzubaidi, L. M. Y., Alenezi, F., Alsoheimi, A. M., Arabe, A. M., Alrshood, A. S., Hassanein, M., & BAKHSH, A. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261427798 · Cited by 1
Living Well With Type 1 Diabetes in Middle School: A Student‐Centered Perspective
Joing, I., Marais, G., Huchez, A., Lespagnol, É., & Heyman, E. (2026) · Psychology in the Schools · doi:10.1002/pits.70172 · Cited by 1
Lou, G., Larramona, G., Gutiérrez, T. M., & Ferrández, S. M. B. (2020) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12350 · Cited by 1
“Considering the coefficient of variation, certain studies relate the use of CGM to a decrease in the coefficient of variation.([7]) However, our results did not find a significantly difference.”
ResultApperley, L. J., Clemente, M., Sultana, P., & Ng, S. M. (2020) · Diabetic Medicine · doi:10.1111/dme.14403 · Cited by 1
Diabetes Device Downloading: Benefits and Barriers Among Youth With Type 1 Diabetes
Palmer, B. A., Soltys, K., Zimmerman, M. B., Norris, A. W., Tsalikian, E., Tansey, M., & Pinnaro, C. T. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211059537 · Cited by 1
The Price of Inequality in Type 1 Diabetes Management
Herringshaw, E. A. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac051 · Cited by 1
Diabetes Technology and Therapy in the Pediatric Age Group
Maahs, D. M., & Shalitin, S. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.2510 · Cited by 1
Self-citationMonitorización individualizada del control glucémico
Ramos, A., & Pérez, A. (2016) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2016.09.014 · Cited by 1
Aguilera, E., & Vázquez, F. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.02.001 · Cited by 1
Avancées technologiques et traitement du diabète
Roy‐Fleming, A., & Taleb, N. (2018) · Nutrition, science en évolution · doi:10.7202/1048943ar · Cited by 1
Ferrández, S. M. B., Gutiérrez, T. M., Ballarín, G. L., Lozano, M. F., & Francés, G. M. L. (2021) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.11.014 · Cited by 1
An Ethical Perspective on the Social Value of Cell-Based Technologies in Type 1 Diabetes
de Jongh, D., & Bunnik, E. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-41943-0_19 · Cited by 1
Price, D. A., Walker, T. C., & Graham, C. (2015) · Diabetes Care · doi:10.2337/dc14-2428
Downloading Diabetes Device Information
Chase, H. P., Owen, S. L., & Slover, R. H. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0172
Self-citationNew Technology for Type 1 Diabetes
Yang, Y., & Cho, J. (2015) · Journal of Korean Diabetes · doi:10.4093/jkd.2015.16.2.123
Initiating Continuous Glucose Monitoring (CGM) Using a Step-Wise Approach
Richardson, C., & Landry, A. (2015)
Regular Evaluation for Patients with Diabetes Mellitus
Koo, B. K. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.4.238
Metadata
- Authors
- Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., Kleis, L., Chase, H. P., DuBose, S. N., Miller, K. M., Beck, R. W., Adi, S., & for the T1D Exchange Clinic Network
- Affiliations
- University of California, San Francisco (US)
- Jaeb Center for Health Research (US)
- University of Colorado Denver (US)
- Park Nicollet Health Services (US)
- Oregon Health & Science University (US)
- University of Southern California (US)
- Atlanta Diabetes Associates (US)
- Northwestern University (US)
- University of Washington (US)
- Spectrum Health (US)
- Corresponding author
- Miller, Kellee M.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-09-10
- Volume
- 37
- Issue
- 10
- Pages
- 2702-2709
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC4392936
- OpenAlex
- W2136450455
- Semantic Scholar
- a3013d7ae63769a7d02f5f5ea02fd388f34dfe01
- Cited by
- 318
- References
- 19
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 15 · 2023: 19 · 2022: 20 · 2021: 27 · 2020: 33 · 2019: 38 · 2018: 45 · 2017: 35 · 2016: 32 · 2015: 29 · 2014: 2
- FWCI
- 26.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (5k12dk094726-05, UL1TR000142)
- National Institute of Diabetes and Digestive and Kidney Diseases (K12-DK094726)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- continuous glucose monitoring, type 1 diabetes, HbA1c, severe hypoglycemia, diabetic ketoacidosis, insulin pump, socioeconomic factors, age differences
- MeSH terms
- Adolescent, Adult, Blood Glucose, Child, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Insulin, Insulin Infusion Systems, Male, Patient Education as Topic, Registries, Retrospective Studies, Risk Factors, Blood Glucose Self-Monitoring, Incidence, Diabetic Ketoacidosis, Monitoring, Ambulatory, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.